As of 2026-09-16, the Intrinsic Value of Rapt Therapeutics Inc (RAPT) is -18.17 USD. This RAPT valuation is based on the model Peter Lynch Fair Value. With the current market price of 58.02 USD, the upside of Rapt Therapeutics Inc is -131.31%.
Based on its market price of 58.02 USD and our intrinsic valuation, Rapt Therapeutics Inc (RAPT) is overvalued by 131.31%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.17 - -18.17 | -18.17 | -131.31% |
| P/E | (67.94) - (84.29) | (73.30) | -226.3% |
| DDM - Stable | (20.90) - (73.06) | (46.98) | -181.0% |
| DDM - Multi | (22.83) - (65.09) | (34.15) | -158.9% |
| Market Cap (mil) | 1,680.26 |
| Beta | 1.34 |
| Outstanding shares (mil) | 28.96 |
| Enterprise Value (mil) | 1,642.33 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.32% |
| Cost of Debt | 5.00% |
| WACC | 8.00% |